Brief: ArriVent Announces Multi-Target ADC Collaboration With Alphamab
05/06/2024 13:10
June 5 (Reuters) - Arrivent Biopharma Inc AVBP.O :
* ARRIVENT ANNOUNCES A MULTI-TARGET ADC COLLABORATION WITH
ALPHAMAB
Source text for Eikon: ID:nGNX7XG4y6
Further company coverage: AVBP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ArriVent BioPharma
See all newsBrief: Arrivent Announces First Patient Dosed With Novel Tetravalent Muc16/Napi2b Dual Target Adc, Arr-002
US RESEARCH ROUNDUP-Allstate, Caribou Biosciences, Zscaler
U.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
ArriVent falls after lung cancer drug misses late-stage trial goal